Barclays maintains Revvity at Equal-Weight, raises price target to $175 from $160

What happened

Barclays maintained its Equal-Weight rating on Revvity and raised its price target to $175 from $160, a 9.4% increase. The new target implies 7.0% upside from the November 3 closing price of $163.48.

Confirmed

Global impact / market context

The higher target signals Barclays sees somewhat more potential value in Revvity shares, but its unchanged Equal-Weight rating indicates it did not upgrade its overall stance. If investors respond to the revised outlook, their buying or selling could influence the share price.

Analyst inference

Recent analyst targets listed in the article range from $160 to $180, with Barclays’ new $175 target within that span. This shows the published estimates differ, so one firm’s revision does not establish a shared view of Revvity’s prospects.

Confirmed

What to watch

1. Compare future analyst updates with Barclays’ $175 target and the other reported estimates; changes in ratings or targets could signal a shift in views about Revvity’s prospects. Analyst inference
2. Watch Revvity’s share price against the article’s $163.48 November 3 close and the new $175 target, while remembering that a target is an analyst estimate, not a guaranteed outcome. Analyst inference
3. The article reports no company results, business changes, or investor reaction, so it does not establish whether revenue, costs, or cash available will change. Confirmed

Evidence

• Original source link unavailable